Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer software/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3.”
    Difference
    0.1%
    Check dated 2026-04-24T06:41:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No changes to the study details or data are visible.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:45.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:13:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, and Revision: v3.4.2 was removed from the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:40:49.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding status notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:30:59.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and Clinical Center status guidance, and updated the site revision to v3.4.1 (replacing v3.4.0); to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:43:12.000Z thumbnail image

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.